DOI:
10.1055/s-00034924
Nuklearmedizin - NuclearMedicine
LinksClose Window
References
Dumont RA, Tamma M, Braun F. et al.
Targeted radiotherapy of prostate cancer with a gastrin-releasing peptide receptor antagonist is effective as monotherapy and in combination with rapamycin.
J Nucl Med 2013;
54: 762-769
We do not assume any responsibility for the contents of the web pages of other providers.